Coherence Neuro

Treating brain cancer with neuromodulation

Human 3 criteria:

Prior evidence of human use

Step change

AI enabled

Coherence is developing the world's first closed loop neuromodulation system to treat Glioblastoma (a deadly brain cancer). Coherence's device is implanted in the brain during routine brain tumor removal surgery. The device then monitors the tumor removal site and uses electrical stimulation to kill any tumor regrowth.

Under the radar for now - more info soon.

2025

XEIA invests

Want more from XEIA?

Stay up to date on Human 3 - the new epoch of health, wellbeing and performance

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! You've been added to our mailing list.
Oops! Something went wrong while submitting the form.
X-disciplinary Exploration, Investment & Acceleration

© 2025 XEIA Venture Partners, LLC